Advertisement
Research Article

The Specificity of the FOXL2 c.402C>G Somatic Mutation: A Survey of Solid Tumors

  • Kasmintan A. Schrader equal contributor,

    equal contributor Contributed equally to this work with: Kasmintan A. Schrader, Bella Gorbatcheva

    Affiliations: Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

    X
  • Bella Gorbatcheva equal contributor,

    equal contributor Contributed equally to this work with: Kasmintan A. Schrader, Bella Gorbatcheva

    Affiliation: Novartis Institute for Biomedical Research, Cambridge, Massachusetts, United States of America

    X
  • Janine Senz,

    Affiliations: Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

    X
  • Alireza Heravi-Moussavi,

    Affiliation: Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada

    X
  • Nataliya Melnyk,

    Affiliations: Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

    X
  • Clara Salamanca,

    Affiliation: Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada

    X
  • Sarah Maines-Bandiera,

    Affiliation: Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada

    X
  • Susanna L. Cooke,

    Affiliation: Cancer Research, Cambridge Research Institute, Cambridge, United Kingdom

    X
  • Peter Leung,

    Affiliation: Department of Obstetrics and Gynecology, University of British Columbia, Child and Family Research Institute, Vancouver, British Columbia, Canada

    X
  • James D. Brenton,

    Affiliation: Cancer Research, Cambridge Research Institute, Cambridge, United Kingdom

    X
  • C. Blake Gilks,

    Affiliation: Genetic Pathology and Evaluation Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada

    X
  • John Monahan,

    Affiliation: Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

    X
  • David G. Huntsman mail

    dhuntsma@bccancer.bc.ca

    Affiliations: Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Novartis Institute for Biomedical Research, Cambridge, Massachusetts, United States of America, Genetic Pathology and Evaluation Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada

    X
  • Published: November 24, 2009
  • DOI: 10.1371/journal.pone.0007988

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.